CAS 914361-45-8

Fosravuconazole L-lysine ethanolate

CAS: 914361-45-8

Fosravuconazole L-lysine ethanolate

Molekulargewicht: 739.734g/mol

Ref: 54-BI12131

Fosravuconazole L-lysine ethanolate

CAS: 914361-45-8

Fosravuconazole L-lysine ethanolate

Reinheit: ≥95%

Molekulargewicht: 739.7g/mol

Ref: 54-BUP05735

Fosravuconazole L-lysine ethanolate

CAS: 914361-45-8

Fosravuconazole L-lysine ethanolate, a prodrug for ravuconazole, treats onychomycosis in Japan.

Formel: C₃₁H₄₀F₂N₇O₈PS

Reinheit: 99.43%

Farbe und Form: Solid

Molekulargewicht: 739.7

Ref: TM-T8847

Fosravuconazole L-Lysine Ethanolate

CAS: 914361-45-8

Formel: C₃₁H₄₀F₂N₇O₈PS

Molekulargewicht: 739.73

Ref: 4Z-F-202005

Fosravuconazole L-Lysine Ethanolate-D₄

Kontrolliertes Produkt

CAS: 914361-45-8

Formel: C₂₃H₁₆D₄F₂N₅O₅PS·C₆H₁₄N₂O₂·C₂H₆O

Farbe und Form: Neat

Molekulargewicht: 743.8

Ref: TR-F729512

Fosravuconazole L-lysine ethanolate

CAS: 914361-45-8

Fosravuconazole L-lysine ethanolate is an antifungal prodrug, which is a derivative of the widely used antifungal agent ravuconazole. This compound is synthesized through chemical modification to enhance its bioavailability and aqueous solubility, addressing limitations found in its parent compound. Fosravuconazole is designed to undergo in vivo conversion to ravuconazole, its active form, by enzymatic processes within the body.

Formel: C₃₁H₄₀F₂N₇O₈PS

Reinheit: Min. 95%

Molekulargewicht: 739.7 g/mol

Ref: 3D-PLB36145

Fosravuconazole L-Lysine Ethanolate

CAS: 914361-45-8

Formel: C₂₃H₂₀F₂N₅O₅PSC₆H₁₄N₂O₂C₂H₆O

Molekulargewicht: 547.47 : 146.2 : 46.1

Ref: ST-EA-CP-F72003

Fosravuconazole L-Lysine Ethanolate

CAS: 914361-45-8

Formel: C₂₃H₂₀F₂N₅O₅PS·C₆H₁₄N₂O₂·C₂H₆O

Molekulargewicht: 739.73

Ref: TR-F521020